Phase 3 Readout~month

Phase 3 Topline: Efficacy and Safety of FMXIN002 Epinephrine Powder Nasal Spray for the Treatment of Acute Allergic R

Indication
Anaphylaxis Food

Other upcoming events for NSRX

Patent ExpiryPatent/Exclusivity Expiry: IDVYNSO
Patent ExpiryPatent/Exclusivity Expiry: FOUNDAYO

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: Efficacy and Safety of FMXIN002 Epinephrine Powder Nasal Spray for the Treatment of Acute Allergic R — NSRX Phase 3 Readout | BioSniper